Committee recommends curbs on freebies doled out by pharma companies

Panel submits its report on a Uniform Code for Pharmaceutical Marketing Practices, says it should remain voluntary

Updated - December 16, 2023 12:17 pm IST

Published - December 13, 2023 10:54 pm IST - New Delhi

Image for representational purposes only.

Image for representational purposes only. | Photo Credit: Getty Images

Disclose the price of branded gifts doled out to doctors, and the gift’s value should not exceed ₹1,000; prohibit continuous medical education (CME) workshops for doctors in foreign locations; money received by registered medical practitioners from pharmaceutical companies to conduct research should be taxable — these are among the recommendations made by a five-member committee headed by Vinod K. Paul to the Union government upon reviewing the Uniform Code for Pharmaceutical Marketing Practices (UCPMP)

(For top health news of the day, subscribe to our newsletter Health Matters)

The committee has recommended that while the UCPMP should remain voluntary in nature, it must be modified. A voluntarily followed UCPMP will not be enforceable under law, and pharma companies may not be penalised for violations. 

The 100-page report submitted to the Department of Pharmaceuticals (DoP) says the value of “brand reminders”, including books, calendars, diaries, journals (including e-journals, dummy device models of body organs, medical books, and clinical treatment guidelines) should not exceed ₹1,000 per item. “The DoP to finalise the list subsequently,” the recommendations state. 

In the case of free drug samples, tax should be deducted at source for the company under the Income Tax (I-T) Act if their value exceeds ₹20,000 per year. “Central Board of Direct Taxes may examine threshold as percentage of sales instead of ₹20,000 in case of free samples,” the panel said. 

CME workshops can be conducted by medical colleges, hospitals, professional associations of doctors, national health research institutes, and trusts and associations of pharma companies, but the committee has separately recommended that organising CMEs in foreign locations be prohibited. 

Moreover, “The organiser of the CME should explicitly spell out the procedure followed in the selection of speakers and participants,” the report said. 

There should be provisions for random, independent audits of CMEs, and pharma companies should share details of such CMEs, including expenses incurred by them on their website, or a common website of the industry association, or the DoP.

Any money given by pharma companies to doctors for permissible research activity will be taxable under the relevant Section of the I-T Act, 1961, the committee has said. 

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.

  翻译: